相关实验视频

Updated: Jan 16, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

在急性胰腺炎中,早期的甘油三降低治疗具有极高的甘油三水平

Lanting Wang¹, Qiong Wu², Enrique de-Madaria³

¹Department of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China (Drs Wang, Cao, Liu, Tong, Li, and Ke); Research Institute of Critical Care Medicine and Emergency Rescue, Nanjing University, Nanjing, China (Drs Wang, Li, and Ke).

Journal of clinical lipidology

|October 1, 2025

概括

在高甘油三血症相关急性胰腺炎 (HTG-AP) 中快速达到目标甘油三水平,可显著降低严重急性胰腺炎 (SAP) 风险. 血酶对治疗SAP或降低甘油三的医疗治疗没有任何优势.

科学领域:

胃肠病学胃肠病学
内分泌学在内分泌学.
关键护理医学关键护理医学

背景情况:

初始的甘油三水平显著影响过高甘油血症相关急性胰腺炎 (HTG-AP) 的甘油三降低疗法的有效性.
了解甘油三下降和疾病严重程度之间的关系对于管理HTG-AP至关重要.

研究的目的:

评估及时降低甘油三和各种甘油三降低疗法是否与HTG-AP患者的疾病严重程度相关,这些患者呈现出极高的甘油三.
为了比较血合成与医疗管理在降低严重急性胰腺炎 (SAP) 风险方面的疗效.

主要方法:

一项基于注册的队列研究,包括90名患者,其入院时的甘油三水平≥45.2 mmol/L.
患者根据第三天的甘油三水平 (目标<5.65 mmol/L与非目标≥5.65 mmol/L) 和治疗方式 (血酶与医疗) 分类.
多变量逻辑回归和概括估计方程模型分析了与严重急性胰腺炎 (SAP) 的关联.

主要成果:

在80名患有第三天甘油三水平的患者中,33.8%的患者达到目标水平.
达到甘油三目标与SAP风险降低有显著的相关性 (OR,0.12;P = .009).
与医疗治疗相比,血酶与降低SAP风险 (OR,1.98;P = .291) 或更快的甘油三下降没有显著的关联.

结论:

及时降低甘油三是降低HTG-AP患者患有非常高甘油三水平的严重急性胰腺炎 (SAP) 风险的关键因素.
在这种患者群体中,血酶似乎没有在SAP发展或降低甘油三的速度方面比医疗疗更有优势.

关键词:

在急性胰腺炎中,过高甘油三血症是什么意思与过高甘油三血症相关的急性胰腺炎.血转化 (Plasmapheresis) 是一个过程.三甲酸甘油三甲酸甘油是什么

更多相关视频

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

相关概念视频

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...